terms |
bevacizumab |
As nouns the difference between terms and bevacizumab
is that
terms is while
bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.
bevacizumab |
|
is likely misspelled.
has no English definition.
As a noun bevacizumab
is a monoclonal antibody used in the treatment of cancer.
bevacizumab |
ranibizumab |
As nouns the difference between bevacizumab and ranibizumab
is that
bevacizumab is a monoclonal antibody used in the treatment of cancer while
ranibizumab is a monoclonal antibody fragment derived from the same parent murine antibody as bevacizumab, used as an antiangiogenic.
cancer |
bevacizumab |
As nouns the difference between cancer and bevacizumab
is that
cancer is cancer while
bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.
treatment |
bevacizumab |
As nouns the difference between treatment and bevacizumab
is that
treatment is the process or manner of treating someone or something while
bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.
antibody |
bevacizumab |
As nouns the difference between antibody and bevacizumab
is that
antibody is (immunology) a protein produced by b-lymphocytes that binds to a specific antigen while
bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.
monoclonal |
bevacizumab |
As nouns the difference between monoclonal and bevacizumab
is that
monoclonal is (immunochemistry) something produced from a single clone, especially a monoclonal antibody while
bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.
As an adjective monoclonal
is (biochemistry) genetically engineered from a single clone; used especially of a protein or antibody.